Trivium Point Advisory LLC has reduced its stake in Zoetis Inc. by 8.1% during the second quarter, selling 1,318 shares. Filings with the Securities & Exchange Commission indicate the firm now holds 14,997 shares of the company’s stock.
Trivium Point Advisory LLC Trims Stake in Zoetis Inc. $ZTS

Key Takeaways:
- Trivium Point Advisory LLC trimmed its Zoetis stake by 8.1%
- The firm sold 1,318 shares in the second quarter
- Its current Zoetis holdings total 14,997 shares
- The information comes from an SEC disclosure
- Watch List News reported the development on 2025-09-30
Trivium Point Advisory’s Quarter Moves
Trivium Point Advisory LLC has made a noteworthy change to its investment portfolio by trimming its stake in Zoetis Inc. According to the latest report, the firm sold some of its Zoetis shares during the second quarter of the year, reflecting a strategic financial decision that reduces its overall holdings in the stock.
SEC Documentation and Disclosure
The information was obtained through a recent filing with the Securities & Exchange Commission (SEC). Publicly available SEC filings play a critical role in offering transparency to investors and the general public, ensuring that changes in investment positions are documented and disclosed.
Details of the Reduced Stake
The filing confirms that Trivium Point Advisory LLC lowered its holdings in Zoetis by 8.1%. This reduction involved the sale of 1,318 shares, leaving the firm with 14,997 shares by the end of the quarter. The exact motivations behind the sale were not detailed in the filing; however, the numbers indicate the extent to which Trivium Point Advisory LLC has chosen to revise its position.
Updates Moving Forward
Though the disclosure is limited in scope, the transaction underscores the importance of monitoring institutional investors and their actions regarding high-profile companies. As with all regulatory filings, further developments may emerge if Trivium Point Advisory LLC or other stakeholders adjust their strategies. For now, the official SEC data stands as a snapshot of the firm’s investment activity in Zoetis during the second quarter.